A detailed history of Arizona State Retirement System transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Arizona State Retirement System holds 22,025 shares of SNDX stock, worth $288,087. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,025
Previous 21,407 2.89%
Holding current value
$288,087
Previous $439,000 3.64%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$17.93 - $24.81 $11,080 - $15,332
618 Added 2.89%
22,025 $423,000
Q2 2024

Aug 05, 2024

BUY
$18.82 - $23.79 $8,092 - $10,229
430 Added 2.05%
21,407 $439,000
Q1 2024

May 07, 2024

BUY
$19.71 - $24.57 $88,024 - $109,729
4,466 Added 27.05%
20,977 $499,000
Q4 2023

Jan 24, 2024

BUY
$11.39 - $21.67 $9,510 - $18,094
835 Added 5.33%
16,511 $356,000
Q3 2023

Nov 06, 2023

BUY
$14.52 - $21.77 $4,138 - $6,204
285 Added 1.85%
15,676 $227,000
Q2 2023

Aug 01, 2023

SELL
$19.35 - $22.31 $2,883 - $3,324
-149 Reduced 0.96%
15,391 $322,000
Q1 2023

Apr 27, 2023

BUY
$20.66 - $28.98 $40,762 - $57,177
1,973 Added 14.54%
15,540 $328,000
Q4 2022

Feb 07, 2023

BUY
$20.64 - $26.24 $11,929 - $15,166
578 Added 4.45%
13,567 $345,000
Q3 2022

Nov 07, 2022

BUY
$18.51 - $24.79 $16,362 - $21,914
884 Added 7.3%
12,989 $312,000
Q2 2022

Jul 28, 2022

BUY
$13.64 - $19.48 $19,423 - $27,739
1,424 Added 13.33%
12,105 $233,000
Q1 2022

May 04, 2022

BUY
$14.84 - $22.15 $3,131 - $4,673
211 Added 2.02%
10,681 $186,000
Q4 2021

Feb 04, 2022

SELL
$15.23 - $22.47 $670 - $988
-44 Reduced 0.42%
10,470 $229,000
Q3 2021

Nov 12, 2021

BUY
$13.87 - $19.8 $3,703 - $5,286
267 Added 2.61%
10,514 $201,000
Q2 2021

Aug 02, 2021

BUY
$13.42 - $25.18 $10,897 - $20,446
812 Added 8.61%
10,247 $176,000
Q1 2021

May 06, 2021

BUY
$19.28 - $24.59 $181,906 - $232,006
9,435 New
9,435 $211,000

Others Institutions Holding SNDX

About Syndax Pharmaceuticals Inc


  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $740M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.